Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$83.56 USD

83.56
141,108

+0.23 (0.28%)

Updated Jun 6, 2024 04:00 PM ET

After-Market: $83.44 -0.12 (-0.14%) 5:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (155 out of 248)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: QIAGEN, Merit Medical, OPKO, Abbott and Abiomed

by Zacks Equity Research

The Zacks Analyst Blog Highlights: QIAGEN, Merit Medical, OPKO, Abbott and Abiomed

Thermo Fisher Unveils Suite of Hematology-Oncology Solutions

by Zacks Equity Research

The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from Thermo Fisher's (TMO) new portfolio of hematology-oncology solutions.

Masimo Releases Favorable Study Results on Pulse Oximetry

by Zacks Equity Research

The pulse oximetry study result should be a major breakthrough for Masimo (MASI) to capture the neonatal patient care market.

Urmimala Biswas headshot

MedTech Lifts S&P 500 Index: 3 Stocks With Upside Potential

by Urmimala Biswas

MedTech stocks play a major role in holding the index up and ending the shortest bear run in the history of S&P 500.

Why Hold Strategy is Apt for Varian Medical (VAR) Stock Now

by Zacks Equity Research

Investor confidence is high in Varian Medical (VAR) stock at the moment.

Here's Why You Should Add NextGen Stock to Your Portfolio Now

by Zacks Equity Research

Investor optimism is high on NextGen (NXGN) stock, thanks to solid prospects.

PerkinElmer's Hand Sanitizer Analyzer to Test for Methanol

by Zacks Equity Research

PerkinElmer's (PKI) Hand Sanitizer Analyzer can help lab professionals and scientists all over the world in their fight against COVID-19.

PerkinElmer Launches Workstations for Coronavirus Testing

by Zacks Equity Research

PerkinElmer's (PKI) scalable and modular explorer automated workstations simplify testing workflows, thereby expediting the process of SARS-CoV-2 RT-PCR testing.

MMSI or ALGN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MMSI vs. ALGN: Which Stock Is the Better Value Option?

Patterson Cos. (PDCO) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Patterson Cos. (PDCO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.

Merit Medical (MMSI) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 933.33% and 13.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Merit Medical (MMSI) Q2 Earnings Expected to Decline

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Merit Medical (MMSI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Merit Medical (MMSI) Looks Good: Stock Adds 6.7% in Session

by Zacks Equity Research

Merit Medical (MMSI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Here's Why You Should Retain Merit Medical (MMSI) for Now

by Zacks Equity Research

Investor confidence is high on Merit Medical (MMSI) stock, thanks to solid prospects.

Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Merit Medical (MMSI) for Now

by Zacks Equity Research

Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.

Merit Medical (MMSI) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical Systems (MMSI) has registered an increase in revenues at both its key operating segments in Q1

Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 40.74% and 5.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Retain NextGen Healthcare Stock Now

by Zacks Equity Research

NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.

Here's Why You Should Hold on to HMS Holdings Stock Now

by Zacks Equity Research

HMS Holdings (HMSY) continues to benefit from strong PI solutions and TPM. However, stiff competition remains a concern.

Masimo Collaborates With Samsung to Help Fight Coronavirus

by Zacks Equity Research

Masimo (MASI) and Samsung Electronics America collaborate to bring Masimo SafetyNet Patient App on the latter's select smartphones for faster distribution of Masimo SafetyNet to COVID-19 patients.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, margin contraction remains a woe.

Earnings Preview: Merit Medical (MMSI) Q1 Earnings Expected to Decline

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.